GleamWall
中文EN

CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Hospital & Medical Service Plans · Nasdaq · SEC CIK 1801170 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY54.5%
TTM net income YoY121.3%
TTM EPS YoY119.6%
Revenue 3-yr CAGR14.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin0.5%
Net margin0.5%
FCF margin4.8%
EBITDA margin0.5%

Returns

ROE3.4%
ROA1.9%
ROIC (approx.)7.2%
Asset turnover4.17x

Leverage & solvency

Liabilities / assets48.1%
Debt / equity0.00x
Current ratio1.55x
Interest coverage—

Cash quality & payout

Operating cash flow / net income10.87x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$759.30M$743.17M$749.19M$487.71M$496.65M$477.62M$462.33M$336.96M
SG&A expense$66.83M$70.30M$74.63M$66.16M$48.95M$48.48M$50.67M$52.29M
Operating income$6.43M$28.00M$27.33M-$49.32M-$24.38M-$10.56M-$1.27M-$21.45M
Interest expense———————$0
Net income$6.43M$28.00M$27.33M-$49.32M-$24.38M-$10.58M-$1.27M-$22.09M
EBITDA$7.04M$28.57M$27.85M-$48.90M-$23.97M-$10.16M-$808,000-$21.10M
EPS (basic)0.010.050.05—-0.05-0.020.00—
EPS (diluted)0.010.050.05—-0.05-0.020.00—
Weighted avg. shares (diluted)557.48M545.45M532.50M—512.74M509.04M497.06M—
Banking
Deposits$15.00M$14.90M$14.80M$14.60M$14.90M$14.70M$14.90M$14.60M
Balance sheet
Cash & equivalents$268.07M$198.84M$173.26M$78.30M$190.06M$188.65M$155.44M$194.54M
Short-term investments$58.57M$39.73M$24.19M$23.13M$10.98M$10.86M$4.66M$27.00M
Current assets$535.06M$485.45M$448.02M$307.86M$330.92M$362.94M$331.41M$343.12M
PP&E, net$7.75M$7.23M$6.90M$6.38M$5.49M$5.20M$5.03M$5.31M
Total assets$753.68M$720.33M$697.73M$541.01M$559.66M$574.99M$583.72M$580.74M
Current liabilities$345.90M$323.33M$336.58M$208.82M$193.45M$201.95M$215.65M$213.52M
Total liabilities$362.81M$344.07M$358.30M$232.31M$218.73M$230.81M$247.64M$239.60M
Shareholders' equity$390.87M$376.26M$339.43M$308.70M$340.93M$344.18M$336.07M$341.14M
Cash flow statement
Operating cash flow$70.38M$25.19M$107.89M-$68.15M$12.10M$5.41M-$16.29M-$85.83M
Capital expenditure$898,000$682,000$854,000$597,000$692,000$569,000$185,000$315,000
Free cash flow$69.48M$24.51M$107.04M-$68.75M$11.41M$4.84M-$16.48M-$86.15M
Investing cash flow-$2.88M-$32,000-$5.07M-$34.99M-$5.42M$35.57M$8.93M-$1.44M
Financing cash flow$1.73M$416,000-$7.86M-$8.61M-$5.27M-$7.76M-$31.74M-$6.14M
Depreciation & amortization$610,000$564,000$515,000$420,000$406,000$394,000$466,000$344,000
Stock-based compensation$8.02M$8.90M$12.27M$24.92M$26.11M$26.20M$26.44M$29.64M
Share buybacks$0$0$0$0$1,000$0$18.30M$0

Free plan shows the latest 8 periods; Pro shows all 28 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.